Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.

Compare up to 10 stocks

Clear

PFE NVS JNJ RHHBY ABT LLY CVS UNH TDOC CRSP

Comparison Results

Name	Price	Price Change	Analyst Price Target	Analyst Consensus	Market Cap	Yearly Gain	Smart Score
PFE Pfizer	$44.19	▼ $0.06 (0.14%)	$51.50 (16.54% Upside)	2 Buy 7 Hold 0 Sell Hold	$252.99B	-13.46%	premium
NVS Novartis	$89.90	▲ $0.06 (0.07%)	―	―	$203.27B	13.13%	premium
JNJ Johnson & Johnson	$168.23	▼ $0.66 (0.39%)	$185.00 (9.97% Upside)	3 Buy 5 Hold 0 Sell Moderate Buy	$443.18B	1.98%	premium
RHHBY Roche Holding	$39.31	▼ $0.07 (0.18%)	$48.00 (22.11% Upside)	0 Buy 1 Hold 1 Sell Moderate Sell	$261.01B	-14.66%	premium
ABT Abbott Labs	$111.15	▲ $0.08 (0.07%)	$123.82 (11.40% Upside)	9 Buy 1 Hold 1 Sell Moderate Buy	$193.54B	-6.13%	premium
LLY Eli Lilly & Co	$346.51	▼ $1.5 (0.43%)	$399.62 (15.33% Upside)	11 Buy 2 Hold 0 Sell Strong Buy	$345.23B	49.02%	premium
CVS CVS Health	$87.85	▲ $0.19 (0.22%)	$116.50 (32.61% Upside)	12 Buy 2 Hold 0 Sell Strong Buy	$112.67B	-17.76%	premium
UNH UnitedHealth	$489.85	▼ $2.63 (0.53%)	$605.54 (23.62% Upside)	12 Buy 1 Hold 0 Sell Strong Buy	$460.17B	8.06%	premium
TDOC Teladoc	$28.23	▲ $0.55 (1.99%)	$31.46 (11.44% Upside)	2 Buy 11 Hold 0 Sell Hold	$4.38B	-58.96%	premium
CRSP Crispr Therapeutics AG	$51.71	▲ $1.24 (2.46%)	$91.30 (76.56% Upside)	8 Buy 4 Hold 0 Sell Moderate Buy	$3.97B	-13.63%	premium

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Abbott: FDA approves Proclaim XR spinal cord stimulation system

Abbott announced that the U.S. FDA has approved its Proclaim XR spinal cord stimulation system to treat painful...

1d ago

ABT

Abbott price target raised to $125 from $110 at Stifel

Stifel analyst Rick Wise raised the firm’s price target on Abbott to $125 from $110 and keeps a...

1d ago

ABT

Medavail to sell certain SpotRx pharmacy assets to CVS Health

MedAvail Holdings (MDVL) announced it has entered into a definitive agreement with CVS Pharmacy (CVS), on behalf of...

1d ago

CVS

MDVL

Roche launches COVID-19 PCR test to detect XBB.1.5 Omicron sub-variant

Roche and its subsidiary TIB Molbiol announced they have developed a COVID-19 PCR test for researchers that detects...

1d ago

Abbott price target raised to $123 from $109 at Raymond James

Raymond James analyst Jayson Bedford raised the firm’s price target on Abbott to $123 from $109 and keeps...

1d ago

ABT

UBS downgrades Pfizer, says COVID estimates need to drop

UBS analyst Colin Bristow downgraded Pfizer to Neutral from Buy with a price target of $47, down from...

1d ago

PFE

Abbott price target raised to $132 from $125 at Bernstein

Bernstein raised its price target on Abbott to $132 from $125 and keeps an Outperform rating on the...

1d ago

ABT

Pfizer downgraded to Neutral from Buy at UBS

UBS analyst Colin Bristow downgraded Pfizer to Neutral from Buy with a price target of $47, down from...

1d ago

PFE

Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

Basel, 26 January 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed...

1d ago

Cathie Wood Gets Back on Track; Here Are 2 Stocks She’s Snapping Up

Cathie Wood made her name by backing growth-oriented and cutting-edge stocks with her Ark Innovation ETF (ARKK) delivering...

2d ago

DNA

NYSE

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Healthcare Stocks

ABT

Abbott Laboratories

premium

Buy

premium

Reiterated

2023-01-27

PFE

Pfizer Inc

premium

Hold

premium

Downgraded

2023-01-26

JNJ

Johnson & Johnson

premium

Hold

premium

Reiterated

2023-01-25

CRSP

Crispr Therapeutics

premium

Buy

premium

Reiterated

2023-01-25

UNH

Unitedhealth Group Inc.

premium

Buy

premium

Reiterated

2023-01-23

LLY

Eli Lilly And Company

premium

Buy

premium

Reiterated

2023-01-23

TDOC

Teladoc Inc.

premium

Buy

premium

Reiterated

2023-01-19

RHHBY

Roche Holding AG

premium

Sell

premium

Downgraded

2023-01-18

CVS

CVS Health Corp

premium

Buy

premium

Reiterated

2023-01-13

NVS

Novartis AG

premium

Hold

premium

Downgraded

2022-05-09

All Ratings >

Most Recent Earnings of Healthcare Stocks

PFE

Pfizer

Nov 01, 2022

2022 (Q3)

1.39 / 1.78

1.34

32.84% (+0.44)

NVS

Novartis

Oct 25, 2022

2022 (Q3)

1.55 / 1.58

1.71

-7.60% (-0.13)

JNJ

Johnson & Johnson

Jan 24, 2023

2022 (Q4)

2.24 / 2.35

2.13

10.33% (+0.22)

RHHBY

Roche Holding

Jul 21, 2022

2022 (Q2)

1.42 / 1.52

1.437

5.50% (+0.08)

ABT

Abbott Labs

Jan 25, 2023

2022 (Q4)

0.93 / 1.03

1.32

-21.97% (-0.29)

LLY

Eli Lilly & Co

Nov 01, 2022

2022 (Q3)

1.91 / 1.98

1.94

2.06% (+0.04)

CVS

CVS Health

Nov 02, 2022

2022 (Q3)

2.00 / 2.09

1.97

6.09% (+0.12)

UNH

UnitedHealth

Jan 13, 2023

2022 (Q4)

5.17 / 5.34

4.48

19.20% (+0.86)

TDOC

Teladoc

Oct 26, 2022

2022 (Q3)

-0.56 / -0.45

-0.53

15.09% (+0.08)

CRSP

Crispr Therapeutics AG

Nov 01, 2022

2022 (Q3)

-2.28 / -2.24

-1.67

-34.13% (-0.57)

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?

These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:

Eli Lilly & Co - Strong Buy, based on 13 analyst ratings, 11 Buy, 2 Hold, and 0 Sell.

CVS Health - Strong Buy, based on 14 analyst ratings, 12 Buy, 2 Hold, and 0 Sell.

UnitedHealth - Strong Buy, based on 13 analyst ratings, 12 Buy, 1 Hold, and 0 Sell.

Are Healthcare stocks overpriced?

Pfizer's stock price is currently $44.19, and its average 12-month price target is $51.50.

Novartis's stock price is currently $89.90, and its average 12-month price target is N/A.

Johnson & Johnson's stock price is currently $168.23, and its average 12-month price target is $185.00.

Roche Holding's stock price is currently $39.31, and its average 12-month price target is $48.00.

Abbott Labs's stock price is currently $111.15, and its average 12-month price target is $123.82.

Eli Lilly & Co's stock price is currently $346.51, and its average 12-month price target is $399.62.

CVS Health's stock price is currently $87.85, and its average 12-month price target is $116.50.

UnitedHealth's stock price is currently $489.85, and its average 12-month price target is $605.54.

Teladoc's stock price is currently $28.23, and its average 12-month price target is $31.46.

Crispr Therapeutics AG's stock price is currently $51.71, and its average 12-month price target is $91.30.

Which Healthcare stocks pay dividends?

Pfizer does not currently pay dividends.

Novartis does not currently pay dividends.

Johnson & Johnson currently pays a dividend of $1.13 which represents an annual dividend yield of 2.63%. Johnson & Johnson's next Ex-dividend date is February 17, 2023 and its next payout date is March 7, 2023.

Roche Holding does not currently pay dividends.

Abbott Labs does not currently pay dividends.

Eli Lilly & Co currently pays a dividend of $1.13 which represents an annual dividend yield of 1.12%. Eli Lilly & Co's next Ex-dividend date is February 14, 2023 and its next payout date is March 10, 2023.

CVS Health does not currently pay dividends.

UnitedHealth does not currently pay dividends.

Teladoc does not currently pay dividends.

Crispr Therapeutics AG does not currently pay dividends.